ライフサイエンスコーパス: Johnson

1 Johnson & Johnson stents were implanted in the SVGs of 1

2 Johnson and Wardle review the effects of palatability an

3 Johnson et al. show that the receptor-binding domain of

4 Johnson S, Bobb JF, Ito K, Savitz DA, Elston B, Shmool J

5 Johnson-Lindenstrauss (JL) matrices implemented by spars

6 Johnson-Mehl-Avrami-Erofeyev-Kholmogorov (JMAEK) and the

7 ransducer--beyond the measured 800 pV Hz-1/2 Johnson noise of the resonant circuit--consists of the q

8 Jacksonville, FL) and etafilcon A (Acuvue 2; Johnson & Johnson Vision Care) lenses were all soaked fo

9 etric halogenation of a simple alkene, and a Johnson-Claisen rearrangement that generates a quaternar

10 .1.0.0(2,4)]heptane, that is formed during a Johnson-Corey-Chaykovsky reaction on a cyclopentenone.

11 Instead, a Johnson-Mehl-Avrami-Kolmogorov model of perimeter-depend

12 th receptor molecules are calculated using a Johnson, Kendall, and Roberts contact mechanics model.

13 Acemoglu, Johnson, and Robinson (abbreviated AJR) established the

14 rofloxacin-HCl-soaked Acuvue lenses (Acuvue; Johnson & Johnson Vision Care, Inc., Jacksonville, FL).

15 (Bausch & Lomb, Rochester, NY) and Acuvue2 (Johnson & Johnson, New Brunswick, NJ) soft contact lense

16 ochester, NY), galyfilcon A (Acuvue Advance; Johnson & Johnson Vision Care), lotrafilcon A and B (Nig

17 Chilcote and Johnson previously studied isolated Tetrahymena 22 S dyn

18 ression developed by Waugh and Fessenden and Johnson and Bovey only quantifies the contribution of ri

19 PIT, thrombin-saturated Gelfoam (Johnson and Johnson, Summerville, NJ) was embolized into the hepatic

20 , the slender body theories of Lighthill and Johnson, and the regularized Stokeslet method.

21 um Pharmaceuticals, Inc., Cambridge, MA, and Johnson & Johnson Pharmaceutical Research & Development,

22 mputerized cluster algorithm of Veldhuis and Johnson.

23 d by using an I-index proposed by Zimmer and Johnson.

24 rmally induced electrical currents, known as Johnson noise, cause fluctuating electric and magnetic f

25 ions of fluoromethyl transfer agents such as Johnson's reagent.

26 rienced sonologists in Telescience Center at Johnson Space Center.

27 romising approach presented in this issue by Johnson et al. is based on the idea of using pharmacolog

28 al survival, the recently published paper by Johnson et al., 'Ancient bacteria show evidence of DNA r

29 a new selection criterion developed by W. C. Johnson, Jr.

30 the predicted values using the widely cited Johnson and Christy data.

31 tion (MOR) on Ru/Pt thin film and commercial Johnson-Matthey PtRu/C, a revised MOR enhancement mechan

32 were 228 DES implanted (83% Cypher [Cordis, Johnson & Johnson, Warren, New Jersey], 17% Taxus [Bosto

33 Velocity stents ((BX Velocity/Sonic, Cordis, Johnson & Johnson) (BMS, n = 65), sirolimus-eluting sten

34 heduled per protocol by the 4 Cypher (Cordis/Johnson & Johnson, Warren, New Jersey) sirolimus-eluting

35 impact of batch effects on microarray data, Johnson, Rabinovic, and Li developed ComBat for use when

36 accumulation of conjugated bilirubin (Dubin-Johnson syndrome).

37 K. Fukuyama, S. S. Abdel-Meguid, J. E. Johnson, and M. G. Rossmann reported the structure of al

38 ple being the inherent voltage fluctuations (Johnson noise) that exist across any resistor, which all

39 mpletion of PIT, thrombin-saturated Gelfoam (Johnson and Johnson, Summerville, NJ) was embolized into

40 athway of ATP hydrolysis follows the Gilbert-Johnson pathway determined previously for a similarsized

41 r major depressive disorder from the Ralph H Johnson Veterans Affairs Medical Center and four associa

42 Halpin, Johnson, and Miller contest our assignment of quantum be

43 3Lys, and was previously described as having Johnson-McMillin syndrome.

44 In this issue of Immunity, Johnson et al. demonstrate a role for DC-expressed CD40L

45 zes the use-availability likelihood given in Johnson et al. (Resource selection functions based on us

46 However, while 9 of 27 such wells in Johnson County were near earthquakes, elsewhere no earth

47 We used the isothermal Johnson-Mehl-Avrami-Kolmogorov (JMAK) model to estimate

48 In this issue, Johnson et al. reveal a heterogeneity in lysosomal pH an

49 In this issue, Johnson et al. shed light on this conundrum using a sing

50 In this issue, Johnson et al. show that a DNA glycosylase derived from

51 Johnson & Johnson stents were implanted in the SVGs of 186 patient

52 le, FL) and etafilcon A (Acuvue 2; Johnson & Johnson Vision Care) lenses were all soaked for 14 hours

53 Lomb, Rochester, NY) and Acuvue2 (Johnson & Johnson, New Brunswick, NJ) soft contact lenses.

54 -HCl-soaked Acuvue lenses (Acuvue; Johnson & Johnson Vision Care, Inc., Jacksonville, FL).

55 NY), galyfilcon A (Acuvue Advance; Johnson & Johnson Vision Care), lotrafilcon A and B (Night & Day A

56 euticals, Inc., Cambridge, MA, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., R

57 tents ((BX Velocity/Sonic, Cordis, Johnson & Johnson) (BMS, n = 65), sirolimus-eluting stents (Cypher

58 DES implanted (83% Cypher [Cordis, Johnson & Johnson, Warren, New Jersey], 17% Taxus [Boston Scientif

59 r protocol by the 4 Cypher (Cordis/Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SE

60 , GA), senofilcon A (Acuvue Oasys; Johnson & Johnson Vision Care, Jacksonville, FL) and etafilcon A (

61 er sirolimus-eluting stents (SES) (Johnson & Johnson, New Brunswick, New Jersey).

62 er balloon injury, biliary stents (Johnson & Johnson) were implanted in the femoral arteries of 14 sw

63 d regenerated cellulose (Surgicel, Johnson & Johnson, New Brunswick, NJ), or pressure.

64 ayesian statistical techniques to update key Johnson-Ettinger input parameters, and we compare the pe

65 notation recently presented by Kirkpatrick, Johnson, and Barton (developed from previous work by Bar

66 Theoretically, we extend the well-known Johnson-Mehl-Avrami-Kolmogorov equation, which describes

67 correction in Nicotiana benthamiana leaves (Johnson et al. in Plant Mol Biol 82(3):207-221, 2013).

68 for its cement protein (CP) and HK97-like ('Johnson') for its major capsid protein (MCP).

69 Laboratories, Columbus, OH] and Casec [Mead-Johnson Nutritionals, Evansville, IN]; n = 18) diet.

70 We used a spatial acuity measure (Johnson-Van Boven-Phillips domes) to evaluate sensory sp

71 24-hour esophageal pH probe and had a median Johnson-DeMeester score of 10 (normal <22.0).

72 Ford Human Investigation Committee and NASA Johnson Space Center Committee for Protection of Human S

73 In this issue of Neuron, Johnson et al. used whole-exome capture to identify VCP

74 on, Duluth, GA), senofilcon A (Acuvue Oasys; Johnson & Johnson Vision Care, Jacksonville, FL) and eta

75 Based on the approach of Johnson et al., I report for the first time the evolutio

76 calculations and validate the feasibility of Johnson's proposed mechanism.

77 the allergenic components of the Panicoideae Johnson grass pollen (JGP; Sorghum halepense).

78 Exceptionally, for perfluorodecalin, Johnson-Kendall-Roberts mechanics was observed.

79 Three months after the case, President Johnson ratified the Civil Rights Act of 1964, which inc

80 nitrogen-vacancy centers in diamond to probe Johnson noise in the vicinity of conductive silver films

81 These methods were then used to reanalyze Johnson et al.'s neuron-restrictive silencer factor (NRS

82 witches and uses thermal noise in resistors (Johnson noise) to pump heat.

83 In this issue of Developmental Cell, Roh-Johnson et al. (2017) reveal that cytoplasmic transfer f

84 dry eye, Meesmann's dystrophy, and Steven's-Johnson syndrome.

85 W. S. Johnson's total synthesis of the sesquiterpenoid longifo

86 Employing high-sensitivity Johnson noise thermometry, we report an order of magnitu

87 pping Cypher sirolimus-eluting stents (SES) (Johnson & Johnson, New Brunswick, New Jersey).

88 itoring the healing of damage on the shallow Johnson Valley fault after its rupture in the 1992 magni

89 These observations indicate that the shallow Johnson Valley fault is strengthening after the main sho

90 After balloon injury, biliary stents (Johnson & Johnson) were implanted in the femoral arterie

91 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (T

92 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (T

93 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (T

94 Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)

95 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN

96 Stevens-Johnson syndrome and toxic epidermal necrolysis are seve

97 Stevens-Johnson syndrome is a well-recognized immune complex-med

98 ucocutaneous reaction described as a Stevens-Johnson syndrome that was attributed to chemotherapy.

99 ophthalmologic treatments for acute Stevens-Johnson syndrome (SJS) as well as the emerging treatment

100 ing bile duct syndrome shortly after Stevens-Johnson syndrome is described; this was temporally assoc

101 , or type I, reactions, anaphylaxis, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

102 relationship between HLA-B*1502 and Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (T

103 Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are rare, acute, life-threatening

104 drug-induced liver injury (DILI) and Stevens-Johnson syndrome (SJS) or toxic epidermal necrosis (TEN)

105 Toxic epidermal necrolysis and Stevens-Johnson syndrome are severe cutaneous drug reactions of

106 o corneal diseases, astigmatism, and Stevens-Johnson syndrome fall within corneal epithelial enhancer

107 (chemical injury in 9 [10 eyes] and Stevens-Johnson syndrome in 5 patients).

108 de in toxic epidermal necrolysis and Stevens-Johnson syndrome may cause the epidermal apoptosis and n

109 and systemic symptoms syndrome, and Stevens-Johnson syndrome/toxic epidermal necrolysis, can be seve

110 ctions (DHR) induced by PPI, such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)

111 aterally blind from diseases such as Stevens-Johnson syndrome, and ocular pemphigoid have little hope

112 chanisms in the pathogenesis of both Stevens-Johnson syndrome and vanishing bile duct syndrome.

113 By comparison, Stevens-Johnson syndrome (SJS) is a life-threatening severe cuta

114 including the blistering conditions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (T

115 for the life-threatening dermatoses Stevens-Johnson syndrome and toxic epidermal necrolysis.

116 s such as graft-versus-host disease, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

117 thy, lattice and Avellino dystrophy, Stevens-Johnson syndrome, and chemical/thermal injury.

118 Patients admitted for Stevens-Johnson syndrome/toxic epidermal necrolysis over a 14-ye

119 ntilation is required in one of four Stevens-Johnson syndrome/toxic epidermal necrolysis patients and

120 s with bronchiolitis obliterans from Stevens-Johnson syndrome often have progressive disease that may

121 icatricial pemphigoid>chemical burns>Stevens-Johnson syndrome.

122 ) lesions are frequently involved in Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN

123 nalyzed 74 cases of SCARs, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)

124 ition to carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)

125 LA-B*57:01 and carbamazepine-induced Stevens-Johnson syndrome and HLA-B*15:02 have been implemented i

126 Three cases of Stevens-Johnson Syndrome (SJS), and 11 cases of Drug Reaction wi

127 Prompt identification of Stevens-Johnson syndrome/toxic epidermal necrolysis patients at

128 n patients with actively progressing Stevens-Johnson syndrome or toxic epidermal necrolysis.

129 Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain a

130 ry group, and 10 (12 laminae) to the Stevens-Johnson syndrome (SJS) group.

131 The underlying diseases were Stevens-Johnson syndrome (22 eyes), Sjogren syndrome (11 eyes),

132 common indications for surgery were Stevens-Johnson syndrome in 41.7% (20 of 48 eyes) and mucous mem

133 One patient with Stevens-Johnson syndrome and 2 patients with floppy eyelids had

134 els and the outcome of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

135 radically positive in a patient with Stevens-Johnson syndrome.

136 1989 and in 1997 assumed the William and Sue Johnson Endowed Chair in Molecular Plant Pathology.

137 ), oxidized regenerated cellulose (Surgicel, Johnson & Johnson, New Brunswick, NJ), or pressure.

138 unique, but all belong to the non-symmetric Johnson solid family, illustrating the potential of this

139 ng the leading and lagging strand templates (Johnson et al, 2015).

140 However, we find that Johnson noise is markedly suppressed next to single-crys

141 The Johnson-Kendall-Roberts (JKR) model was used to relate t

142 The Johnson-Kendall-Roberts theory is the basis of modern co

143 The Johnson-Mehl-Avrami model was used to determine the acti

144 component seismic arrays deployed across the Johnson Valley fault trace.

145 y of MCP is permuted non-circularly from the Johnson fold topology previously seen in viral and cellu

146 ead to a larger signal that emerges from the Johnson noise of the current amplifier.

147 n approach for improving the accuracy of the Johnson-Ettinger model (JEM), which the Environmental Pr

148 strongly shook and permanently strained the Johnson Valley fault, adding damage discernible as a tem

149 Analysis using the Johnson-Kendall-Roberts, Derjaguin-Muller-Toporov, and H

150 We show that, whereas the Johnson-Kendall-Roberts theory holds for particles large

151 plate ion detectors are limited by thermal (Johnson) noise in the associated electronics.

152 ter and simpler measurement than traditional Johnson noise thermometry, making it potentially attract

153 en utilized in a Claisen rearrangement under Johnson's conditions to introduce a side chain that is f

154 verted question mark4-HPR, Fenretinide; R.W. Johnson Pharmaceutical Research Institute, Springhouse,

155 pants were the 36 members of the Robert Wood Johnson Foundation (RWJF) Critical Care End-of-Life Peer

156 Robert Wood Johnson Foundation and the U.S. Department of Veterans A

157 Robert Wood Johnson Foundation Clinical Scholars Program, National I

158 Robert Wood Johnson Foundation Clinical Scholars Program, National I

159 ns Health Administration and The Robert Wood Johnson Foundation Clinical Scholars Program.

160 rlier and ongoing efforts of the Robert Wood Johnson Foundation Critical Care End-of-Life Peer Workgr

161 Robert Wood Johnson Foundation Health and Society Scholars Program.

162 City of New York and the Robert Wood Johnson Foundation Healthy Eating Research program.

163 the future of primary care, the Robert Wood Johnson Foundation sponsored a meeting in October 2001 i

164 The Robert Wood Johnson Foundation's Pioneer Portfolio, Drane Family Fun

165 US Food and Drug Administration, Robert Wood Johnson Foundation, and Janssen Biotech.

166 onal Institute of Mental Health, Robert Wood Johnson Foundation, California Community Foundation, Nat

167 The Robert Wood Johnson Foundation, the Drane Family Fund, the Richard a

168 million national program of the Robert Wood Johnson Foundation, was developed to recruit leaders fro

169 nal Institute on Drug Abuse, and Robert Wood Johnson Foundation.

170 ncer Institute of New Jersey and Robert Wood Johnson Foundation.

171 Primary Funding Source: Robert Wood Johnson Foundation.

172 partment of Veterans Affairs and Robert Wood Johnson Foundation.

173 ational Institutes of Health and Robert Wood Johnson Foundation.

174 Institute on Drug Abuse and the Robert Wood Johnson Foundation.

175 Commonwealth Fund and Robert Wood Johnson Foundation.

176 nal Institutes of Health and the Robert Wood Johnson Foundation.

177 hange, a national program of the Robert Wood Johnson Foundation.

178 of Healthcare Quality Promotion; Robert Wood Johnson Foundation; US Department of Veterans Administra

179 ber Education grant program, the Robert Wood Johnson Pioneer Program, and the National Cancer Institu

180 skin antisepsis was performed at Robert Wood Johnson University Hospital (RWJUH).

181 2004 through 31 December 2005 at Robert Wood Johnson University Hospital and Duke University Medical

182 est-Revised); academic achievement (Woodcock-Johnson Tests of Achievement-Revised); and parental repo

183 es, and Calculation subtests of the Woodcock-Johnson III Tests of Achievement (96+/-13 and 97+/-16; 1

184 psychological evaluations using the Woodcock-Johnson Tests of Cognitive Abilities Third Edition (medi